Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

S&P Biotech SPDR (XBI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund basics

See More

Price Performance

See More
Period Period Low Period High Performance
1-Month
91.91 +9.41%
on 06/28/18
101.55 -0.97%
on 06/21/18
+3.38 (+3.48%)
since 06/13/18
3-Month
85.07 +18.21%
on 04/25/18
101.55 -0.97%
on 06/21/18
+10.98 (+12.26%)
since 04/13/18
52-Week
74.25 +35.43%
on 08/10/17
101.55 -0.97%
on 06/21/18
+21.38 (+27.00%)
since 07/13/17

Most Recent Stories

More News
What Investors Need to Know about Biotech ETFs

Smaller biotech stocks are outperforming this year; learn more about biotech ETFs best positioned to benefit

IBB : 118.35 (+0.17%)
FBT : 150.77 (+0.03%)
XBI : 100.56 (-0.28%)
What Investors Need to Know about Biotech ETFs

Smaller biotech stocks are outperforming this year; learn more about biotech ETFs best positioned to benefit

IBB : 118.35 (+0.17%)
FBT : 150.77 (+0.03%)
XBI : 100.56 (-0.28%)
Sarepta Pharma Pushes Two Biotech ETFs to New Highs

The encouraging early trial results for a gene therapy for Duchenne muscular dystrophy pushed Sarepta Therapeutics and few biotech ETFs to new highs.

BBP : 46.70 (+0.80%)
SLDB : 42.35 (+3.32%)
BBC : 34.48 (unch)
SBIO : 38.81 (-0.56%)
SRPT : 139.42 (+1.42%)
IBB : 118.35 (+0.17%)
VRTX : 180.50 (+1.25%)
ALNY : 107.47 (-0.54%)
XBI : 100.56 (-0.28%)
ALXN : 135.87 (+1.18%)
BIIB : 348.48 (+0.24%)
Sarepta Pharma Pushes Two Biotech ETFs to New Highs

The encouraging early trial results for a gene therapy for Duchenne muscular dystrophy pushed Sarepta Therapeutics and few biotech ETFs to new highs.

BBP : 46.70 (+0.80%)
SLDB : 42.35 (+3.32%)
BBC : 34.48 (unch)
SBIO : 38.81 (-0.56%)
SRPT : 139.42 (+1.42%)
IBB : 118.35 (+0.17%)
VRTX : 180.50 (+1.25%)
ALNY : 107.47 (-0.54%)
XBI : 100.56 (-0.28%)
ALXN : 135.87 (+1.18%)
BIIB : 348.48 (+0.24%)
Should You Invest in the PowerShares Dynamic Biotechnology & Genome Portfolio (PBE)?

Sector ETF report for PBE

PBE : 59.14 (-0.08%)
ILMN : 306.99 (+0.75%)
IBB : 118.35 (+0.17%)
QGEN : 37.10 (-0.67%)
XBI : 100.56 (-0.28%)
BIIB : 348.48 (+0.24%)
Why These Small Cap Biotech ETFs are Soaring

These biotech ETFs have surged this year thanks mainly to tax reform, rising M&A and positive regulatory backdrop.

BBC : 34.48 (unch)
CNCR : 25.04 (-0.44%)
IBB : 118.35 (+0.17%)
PSCH : 134.52 (-0.37%)
XBI : 100.56 (-0.28%)
Why These Small Cap Biotech ETFs are Soaring

These biotech ETFs have surged this year thanks mainly to tax reform, rising M&A and positive regulatory backdrop.

BBC : 34.48 (unch)
CNCR : 25.04 (-0.44%)
IBB : 118.35 (+0.17%)
PSCH : 134.52 (-0.37%)
XBI : 100.56 (-0.28%)
Strong Week Despite Weak Finish

Strong Week Despite Weak Finish

YY : 98.43 (+0.88%)
CPA : 97.38 (+1.17%)
INTT : 7.30 (+0.69%)
SNE : 53.31 (+2.11%)
XBI : 100.56 (-0.28%)
AMZN : 1,813.03 (+0.91%)
Is PowerShares Dynamic Biotechnology & Genome Portfolio (PBE) a Hot ETF Right Now?

Smart Beta ETF report for PBE

PBE : 59.14 (-0.08%)
ILMN : 306.99 (+0.75%)
IBB : 118.35 (+0.17%)
VRTX : 180.50 (+1.25%)
REGN : 367.64 (+0.33%)
XBI : 100.56 (-0.28%)
4 Sector ETFs That Crushed S&P 500 in 9-Year Bull Run

These sector ETFs emerged winners in the nine-year bull market.

RYH : 191.25 (+0.38%)
FDN : 145.08 (-0.68%)
XLY : 112.59 (+0.22%)
VCR : 174.41 (+0.41%)
PSJ : 81.01 (-0.01%)
PJP : 70.51 (-0.41%)
QTEC : 80.40 (-0.25%)
FXH : 77.41 (+0.14%)
FBT : 150.77 (+0.03%)
SOXX : 181.92 (-0.36%)
SPY : 279.59 (+0.08%)
XBI : 100.56 (-0.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade XBI with:

Fund Summary

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

See More

Key Turning Points

2nd Resistance Point 101.47
1st Resistance Point 101.01
Last Price 100.56
1st Support Level 100.14
2nd Support Level 99.73

See More

52-Week High 101.55
Last Price 100.56
Fibonacci 61.8% 91.12
Fibonacci 50% 87.90
Fibonacci 38.2% 84.68
52-Week Low 74.25

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar